New program aims to prevent relationship abuse in LGBTQ+ youth
NCT ID NCT07718022
First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time
Summary
This pilot trial tests a program called FLARE, designed to prevent relationship abuse among sexual and gender diverse youth (ages 14-18) and their trusted adults. The program includes in-person, virtual, and self-paced activities created with input from teens and caregivers. The study measures how acceptable and feasible the program is, and whether it improves recognition of abusive behaviors and attitudes toward diverse identities.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- FLARE, a behavioral intervention for adolescent relationship abuse prevention
- What this could lead to
- If successful, this program could help prevent relationship abuse among sexual and gender diverse youth by improving recognition of abusive behaviors and fostering healthier relationships.
- What could go wrong
- This is a small pilot trial focused on feasibility, not effectiveness. The program may not work as intended or may not be widely adopted.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADOLESCENT RELATIONSHIP ABUSE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.